Chow, 112,070 patient aspirin late treatment study: 13% lower mortality [p<0.0001] https://c19p.org/chow3
copied to clipboard
Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19
et al., JAMA Network Open, doi:10.1001/jamanetworkopen.2022.3890
Retrospective 112,269 hospitalized COVID-19 patients in the USA, showing lower mortality with aspirin treatment.
|
risk of death, 13.5% lower, RR 0.87, p < 0.001, treatment 1,410 of 13,795 (10.2%), control 11,577 of 98,275 (11.8%), NNT 64, adjusted per study, odds ratio converted to relative risk, inverse propensity weighting.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Chow et al., 3/24/2022, retrospective, USA, North America, peer-reviewed, median age 63.0, 89 authors.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.